Immunogenicity 10830
Sample ID
3678
Response
Negative
Tumor Type
Melanoma
Gene Symbol
ELOVL2
Transcript ID
None
HLA INFO
C*14:02
TCR INFO
No TCR info found!
Full length protein sequence (296 aa)
MEHLK
1
AFDDE
6
INAFL
11
DNMFG
16
PRDSR
21
VRGWF
26
MLDSY
31
LPTFF
36
LTVMY
41
LLSIW
46
LGNKY
51
MKNRP
56
ALSLR
61
GILTL
66
YNLGI
71
TLLSA
76
YMLAE
81
LILST
86
WEGGY
91
NLQCQ
96
DLTSA
101
GEADI
106
RVAKV
111
LWWYY
116
FSKSV
121
EFLDT
126
IFFVL
131
RKKTS
136
QITFL
141
HVYHH
146
ASMFN
151
IWWCV
156
LNWIP
161
CGQSF
166
FGPTL
171
NSFIH
176
ILMYS
181
YYGLS
186
VFPSM
191
HKYLW
196
WKKYL
201
TQAQL
206
VQFVL
211
TITHT
216
MSAVV
221
KPCGF
226
PFGCL
231
IFQSS
236
YMLTL
241
VILFL
246
NFYVQ
251
TYRKK
256
PMKKD
261
MQEPP
266
AGKEV
271
KNGFS
276
KAYFT
281
AANGV
286
MNKKA
291
Q
296
Mutation Information
DNA mutation:
None
Peptide Range:
246 ~ 270
Mut AA position:
258 (13 in Wild Type peptide)
Alignment
Wild Type:
"VILFLNFYVQTYRKKPMKKDMQEPP
||||||||||||.||||||||||||
Mutant:
VILFLNFYVQTYQKKPMKKDMQEPP"
Clin Cancer Res, 2017
Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 ExpressionGene Name (from Reference) ELOVL2
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
TILs
APC
Type
autologous DCs
Assay
ELISPOT assay